Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2021-03-09 Director's Dealing
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
110年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions by company directors and executives (insider trades). Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2021-03-09 Chinese
110年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledges of shares by company insiders, including directors, supervisors, and senior management. It includes specific data on share counts, pledges, and related parties. The content focuses on insider shareholdings and their changes, which aligns with reporting of personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document length is under 5,000 characters and is a detailed insider shareholding report rather than a brief announcement or certification. Therefore, the document fits best into the 'Director's Dealing' category.
2021-03-09 Chinese
董事會決議股利分派
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (764 characters) from a company (1762 中化生) regarding a board resolution on dividend distribution for the fiscal year 109 (2020). It details the cash dividend per share, total cash dividend amount, and confirms no stock dividends or capital increases. There is no detailed financial data or comprehensive report content, only a dividend distribution decision. This fits the definition of a Notice of Dividend Amount (DIV) rather than a full financial report or other filing types. The document is not a report publication announcement or regulatory filing as it contains substantive dividend details. Therefore, the classification is DIV with high confidence.
2021-03-04 Chinese
本公司配合簽證會計師事務所內部組織調整更換會計師
Audit Report / Information Classification · 95% confidence The document is a short announcement regarding a change in the company's auditor due to internal organizational adjustments within the accounting firm. It includes details about the old and new auditors and the reasons for the change. There are no financial statements, detailed audit reports, or comprehensive financial data presented. The document is brief (1076 characters) and serves as a regulatory announcement about auditor changes rather than a full audit report or annual report. Therefore, it fits best under Audit Report / Information (AR), which covers standalone audit reports and related announcements about auditors, excluding full annual reports.
2021-03-04 Chinese
公告本公司董事會通過109年度合併財務報告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) reporting that the board of directors has approved the consolidated financial report for the fiscal year 109 (covering 109/01/01 to 109/12/31). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity. The document is short (900 characters) and appears to be a formal announcement of the board's approval of the annual consolidated financial report rather than the full annual report itself. There is no indication that the full report is attached or included, only that the board has approved it. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about the approval of the financial report, not the full Annual Report (10-K) itself.
2021-03-04 Chinese
公告本公司董事會決議召開110年股東常會相關事宜
AGM Information Classification · 95% confidence The document is a public announcement from a company (1762 中化生) regarding the board of directors' resolution to convene the 110th Annual General Meeting (AGM) of shareholders. It includes details such as the date and location of the AGM, agenda items including reports, approvals, discussions, and other procedural matters. The document does not contain the actual AGM materials or presentations but rather announces the meeting and its agenda. The document length is short (1153 characters), and it serves as a notice of the AGM rather than the AGM report or presentation itself. Therefore, it fits the category of AGM Information (AGM-R).
2021-03-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.